Powered by
DETROIT—Officials at the Barbara Ann Karmanos Cancer Institute announced that its National Cancer Institute (NCI) Core Grant has been renewed. This renewal extends Karmanos’ prestigious NCI designation through 2025, making …
ANN ARBOR—HistoSonics Inc. announced that it had received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin a clinical trial of its new technology, …
DETROIT—The Barbara Ann Karmanos Cancer Institute announced that Eric A. Brown, M.D., FACS, breast surgeon, has joined its medical team, effective April 20. Board certified in general surgery and breast ultrasound, …
ANN ARBOR—Genomenon, the Ann Arbor genomic search engine provider, announced that the latest release of its Mastermind® Genomic Search Engine includes the ability to search by therapy. Mastermind users can …
ANN ARBOR—Celsee Inc., the single-cell isolation and analysis developer, announced an agreement to provide scientists at China’s Kindstar Global, a medical testing service,with Celsee’s Genesis System for monitoring circulating tumor …
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, announced that it has raised $22.2 million in a Preferred …
ANN ARBOR—An Ann Arbor company that has developed a system to screen cancer patients to precision-designed treatments that will be most effective for them has a new clinical development collaboration …
ANN ARBOR—Strata Oncology, a developer of cancer testing technology for hospitals and the pharmaceutical industry, announced the launch of version 3.0 of StrataNGS, its pan-cancer assay for solid tumors. The …
HOUGHTON – Determining the presence of cancer, as well as its type and malignancy, is a time-consuming process – patients can wait up to two stressful weeks for a diagnosis. …